Treatment of doxorubicin extravasation with intravenous dexrazoxane in a cat.
Mahoney
Jennifer A
JA
Donaldson-Atwood Cancer Center and Flaherty Comparative Oncology Laboratory, The Animal Medical Center, New York, NY 10021, USA.
Bergman
Philip J
PJ
Camps-Palau
Maria A
MA
Hull
Terra L
TL
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D002371:Cat Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D002415:Cats; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000188:drug therapy / Q000662:veterinary*; D005260:Female; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008223:Lymphoma / Q000188:drug therapy / Q000662:veterinary; D011929:Razoxane / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000662:veterinary
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D011929:Razoxane; D004317:Doxorubicin